Join the Allergic Reactions group to help and get support from people like you.
Allergic Reactions News (Page 4)
Related terms: Allergic Drug Reaction, Allergic
Epinephrine: Tips to the 'EpiPen' Ingredient and How It Treats Anaphylaxis
TUESDAY, Oct. 8, 2024 --- The recent approval of a new epinephrine nasal spray, Neffy, gives patients a powerful new way to keep life-threatening allergic reactions at bay. But that doesn't mean...
Yellowjackets and Bees Swarm in NC in Helene's Aftermath
MONDAY, Oct. 7, 2024 – Even as folks in North Carolina continue to clean up following the devastation of Hurricane Helene, a new health danger has emerged: The massive flooding that swept away roads...
Yellowjackets and Bees Swarm in NC in Helene's Aftermath
MONDAY, Oct. 7, 2024 – Even as folks in North Carolina continue to clean up following the devastation of Hurricane Helene, a new health danger has emerged: The massive flooding that swept away roads...
Food Allergies Spur Serious Anxiety in Most of Those Affected, Survey Finds
FRIDAY, Oct. 4, 2024 – The large majority of people with food allergy, and the caregivers of kids with such allergies, say the condition has led to psychological distress, a new study finds....
Indoor Allergens Worsen Respiratory Infections in Children With Asthma
WEDNESDAY, Sept. 25, 2024 – Cockroach and mouse allergen exposure may predispose children with asthma to upper respiratory infections (URIs) and worse respiratory outcomes, according to a study...
Some Chocolate Products Labeled 'Dairy-Free' Contain Milk, FDA Finds
THURSDAY, Sept. 19, 2024 – Consumers should be aware that some chocolate labeled as “dairy-free” actually contains milk, the U.S. Food and Drug Administration warns. This inaccurate labeling could pu...
FDA Approves neffy (epinephrine nasal spray) Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
SAN DIEGO, Aug. 09, 2024 (GLOBE NEWSWIRE) – ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients...
FDA Medwatch Alert: FDA Alerts Patients and Health Care Professionals that Some EpiPen Auto-Injectors May Not Readily Slide Out of Carrier Tube
[11/2/2018] FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions,...
FDA Approves Kaléo’s Auvi-Q (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
Richmond, VA (November 20, 2017) kaléo, a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application ...
Adamis Pharmaceuticals Receives FDA Approval for Symjepi (epinephrine) Pre-Filled Syringe
SAN DIEGO, June 15, 2017 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) (“Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ EPINEP...
FDA Medwatch Alert: EpiPen and and EpiPen Jr Auto-Injector: Recall - Failure to Activate Device
ISSUE: Mylan N.V. announced that Meridian Medical Technologies, a Pfizer company and Mylan’s manufacturing partner for EpiPen Auto-Injector, has expanded a voluntary recall of select lots of EpiPen (...
FDA Approves Odactra for House Dust Mite Allergies
March 1, 2017 – The U.S. Food and Drug Administration today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced...
FDA Medwatch Alert: Auvi-Q (epinephrine injection, USP): Recall - Potential Inaccurate Dosage Delivery
ISSUE: Sanofi US is voluntarily recalling all Auvi-Q (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for...
FDA Approves Tris Pharma's New Drug Application for Karbinal ER
MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ – Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food...
Sanofi Announces FDA Approval for Auvi-Q, First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies
PARIS, Aug. 13, 2012 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) has approved Audi-Q (epinephrine injection, USP) for the emergency treatment of...
Further information
Related condition support groups
Related drug support groups
prednisone, Benadryl, triamcinolone, diphenhydramine, loratadine, promethazine, Phenergan, epinephrine, EpiPen, cyproheptadine